Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.534
-0.021 (-3.75%)
At close: Dec 5, 2025, 4:00 PM EST
0.540
+0.006 (1.09%)
After-hours: Dec 5, 2025, 7:59 PM EST
Adicet Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Adicet Bio stock have an average target of 8.50, with a low estimate of 8.00 and a high estimate of 9.00. The average target predicts an increase of 1,491.16% from the current stock price of 0.53.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Adicet Bio stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $9 | Strong Buy | Maintains | $4 → $9 | +1,584.76% | Nov 7, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +1,397.57% | Oct 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,210.37% | Sep 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +648.78% | Jul 23, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,210.37% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.14
from -1.33
EPS Next Year
-0.81
from -1.14
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.08 | -0.69 | ||||
| Avg | -1.14 | -0.81 | ||||
| Low | -1.23 | -1.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.